| Literature DB >> 25895817 |
Azucena Salas1, Julián Panés1.
Abstract
The suppression of excessive immune responses by infusion of regulatory T cells would require a product of high purity, adequate ex vivo expansion and functional stability. A description of the process to obtain an autologous cell product fulfilling these characteristics paves the way to develop clinical trials in humans.Entities:
Mesh:
Year: 2015 PMID: 25895817 DOI: 10.1038/nrgastro.2015.68
Source DB: PubMed Journal: Nat Rev Gastroenterol Hepatol ISSN: 1759-5045 Impact factor: 46.802